Evidence map›Paper›PMID 40873386›Full record

ArticleACS applied materials & interfaces2025

Hexagonal Bismuthene and Bismuth Nanoparticles for Light-To-Heat Conversion.

Marta Alcaraz, Pau Congost-Escoin, Christian Dolle, Josep Canet-Ferrer, Gonzalo Abellán

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marta AlcarazInstituto de Ciencia Molecular (ICMol), Universidad de Valencia, 46980 Paterna, Spain.ORCID 0000-0002-6667-031X
Pau Congost-EscoinInstituto de Ciencia Molecular (ICMol), Universidad de Valencia, 46980 Paterna, Spain.ORCID 0000-0002-9004-6576
Christian DolleInstituto de Ciencia Molecular (ICMol), Universidad de Valencia, 46980 Paterna, Spain.
Josep Canet-FerrerInstituto de Ciencia Molecular (ICMol), Universidad de Valencia, 46980 Paterna, Spain.ORCID 0000-0002-7221-1873
Gonzalo AbellánInstituto de Ciencia Molecular (ICMol), Universidad de Valencia, 46980 Paterna, Spain.ORCID 0000-0003-1564-6210

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bismuth is an inexpensive, biocompatible, and semimetallic material. Light absorption in bismuth occurs by means of intraband transitions from mid-IR to UV due to its exotic electronic structure. Thus, bismuth has been pointed out as an excellent material in applications relying on optical absorption, such as computed tomography, photocatalysis, and photothermal therapy. Herein, we present an extensive study of the unexplored thermo-optical response of high-quality bismuth nanomaterials: hexagonal bismuthene (hBi) and spherical bismuth nanoparticles (sBiNPs). We observed the light-to-heat conversion (LHC) performance of both compared to that of functionalized Au NPs (NPs) as an alternative to plasmonic NPs for LHC applications. As a result, we have illustrated the potential of bismuth NPs and bismuthene for thermo-optical applications, demonstrating the potential of bismuth NPs and bismuthene for thermo-optical applications, with precise local heating quantified via Raman thermometry. Under 2.1 mW excitation at 633 nm, maximum temperatures of 425 K for AuPMBT, 400 K for sBiNPs, and 325 K for hBi were reached. These values highlight the competitive LHC efficiency of bismuth-based nanostructures, especially sBiNPs, and reveal the influence of thermal diffusion in 2D systems like hBi.

Indexed as

bismuthenebismuth nanoparticlesgold nanoparticleslight-to-heat conversionRaman thermometrysurface plasmon resonance calculations

Identifiers

PMID40873386
PMCPMC12442010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.